Rosen, national trial lawyers, encourages regeneron pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action - regn

New york, ny / access newswire / january 22, 2025 / why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of regeneron pharmaceuticals, inc. (nasdaq:regn) between november 2, 2023 and october 30, 2024, both dates inclusive (the "class period"), of the important march 10, 2025 lead plaintiff deadline. so what: if you purchased regeneron securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
REGN Ratings Summary
REGN Quant Ranking